MinireviewBlood–brain barrier properties of human immunodeficiency virus antiretrovirals
References and Notes (58)
- et al.
The role of the blood brain barrier in HIV infection of the central nervous system
Adv. Neuroimmuno.
(1994) - et al.
HIV infection of human brain capillary endothelial cells ‐ implications for AIDS dementia
Adv. Neuroimmun.
(1994) - et al.
In vitro blood‐brain barrier permeability of nevirapine compared to other HIV antiret‐roviral agents
J. Pharm. Sci.
(1998) - et al.
Methods for quantifying the transport of drugs across brain barrier systems
Pharmacol. Ther.
(1981) - et al.
Cerebrospinal fluid HIV‐1 RNA and drug concentrations after treatment with lamivudine plum zi‐dovudine or stavudine
Lancet
(1998) - et al.
Indinavir in cerebrospinal fluid of HIV‐1 infected patients
Lancet.
(1997) - et al.
Comparisons of P‐glycoprotein in isolated rat brain microves‐sels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta
FEBS Lett.
(1995) - et al.
Zidovudine transport in the rabbit brain during intravenous and intracerebroventricular infusion
J. Pharm. Sci.
(1995) - et al.
Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection
Life Sci.
(1990) - et al.
Early viral brain invasion in iatrogenic human immunodeficiency virus infection
Neurology
(1992)
High levels of unintegrated HIV‐1 DNA in brain tissue of AIDS dementia patients
Nature
(1990)
Dementia associated with the acquired immunodeficiency syndrome
N. Engl. J. Med.
(1995)
Human immunodeficiency virus and the central nervous system
Annu. Rec. Microbiol.
(1992)
Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood‐brain barrier
Ann. Neu‐trol.
(1993)
Absence of humorally mediated damage within the central nervous system of AIDS patients
Neurology
(1989)
Targeting HIV therapy for the brain
HIV: Adv. Res. Ther.
(1998)
Characterization of an in vitro blood‐brain barrier model system for studying drug transport and metabolism
Pharm. Res.
(1986)
Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial
Ann. Neurol.
(1993)
Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV‐1 infected patients
J. Acquired Immune Defic. Synd. Hum. Retrovirol.
(1997)
The entry of antiviral and antiretroviral drugs into the central nervous system
J. Neurol. Virol.
(1997)
The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine
J. Infect. Dis.
(1997)
AID dementia complex and didanosine
Lancet
(1994)
Long‐term zidovudine reduces neurocogni‐tive deficits in HIV‐1 infection
AIDS
(1995)
Declining incidence of AIDS dementia complex after introduction of zidovudine treatment
Br. Med. J.
(1989)
Physicians' Desk Reference
(1998)
Randomized, controlled phase I/II trail of combination therapy with delavirdine (U‐910152S) and conventional nucleosides in HIV‐1 infected patients
Antimicrob. Agents Chemother.
(1996)
Cited by (19)
QSAR analysis of blood-brain distribution: The influence of plasma and brain tissue binding
2011, Journal of Pharmaceutical SciencesPreparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications
2010, Carbohydrate PolymersNeurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: A global perspective
2007, European Journal of Paediatric NeurologyCitation Excerpt :Two properties of HIV-1 CNS infection can reduce the efficacy of antiretroviral treatment at the level of the CNS. First, the ability of antiretroviral drugs to cross the blood–brain barrier is variable, with protease inhibitors in particular having poor CNS penetration.34–36 This could limit the drugs’ effectiveness and may result in the emergence of drug-resistant populations.
Enhancement of brain distribution of anticancer agents using ΔG, the 12 kDa active fragment of ZOT
2005, International Journal of PharmaceuticsBrain Microvessel Endothelial Cell Cultures as in Vitro Models to Study the Blood-Brain Barrier
2004, Blood-Spinal Cord and Brain Barriers in Health and Disease
Copyright © 1999 Wiley-Liss, Inc. and the American Pharmaceutical Association. Published by Elsevier Inc. All rights reserved.